MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the quarter ending 2026-03-31, RGNX made $6,393K in revenue. -$90,234K in net income. Net profit margin of -1411.45%.

Income Overview

Revenue
$6,393K
Net Income
-$90,234K
Net Profit Margin
-1411.45%
EPS
-$1.72
Unit: Thousand (K) dollars
Revenue Breakdown
    • License And Service
    • Service

Income Statement
2026-03-31
2025-12-31
2025-09-30
2025-06-30
Revenues
6,393 30,337 29,733 21,359
Cost of license and royalty revenues
11,074 5,928 5,725 5,209
Research and development
57,339 59,611 56,101 59,500
General and administrative
21,306 22,380 20,253 19,883
Other operating expenses
-36 -54 -65 -45
Total operating expenses
89,755 87,973 82,144 84,637
Income (loss) from operations
-83,362 -57,636 -52,411 -63,278
Interest income from licensing
16 18 19 21
Investment income
2,003 2,745 3,620 3,379
Interest expense
8,708 12,276 13,169 10,993
Total other income (expense)
-6,689 -9,513 -9,530 -7,593
Net income (loss)
-90,051 -67,149 -61,941 -70,871
Unrealized gain on available-for-sale securities, net
-183 -35 98 12
Total other comprehensive gain
-183 -35 98 12
Comprehensive income (loss)
-90,234 -67,184 -61,843 -70,859
Basic EPS
-1.72 -1.298 -1.2 -1.38
Diluted EPS
-1.72 -1.3 -1.2 -1.38
Basic Average Shares
52,428,000 51,758,000 51,689,000 51,483,000
Diluted Average Shares
52,428,000 51,686,000 51,689,000 51,483,000
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Income Statement

DownloadDownload image
Comprehensive income (loss)-$90,234K (-1588.52%↓ Y/Y)Net income (loss)-$90,051K (-1580.37%↓ Y/Y)Total othercomprehensive gain-$183K (-771.43%↓ Y/Y)License And Service$5,090K (-94.15%↓ Y/Y)Service$1,303K (-33.62%↓ Y/Y)Income (loss) fromoperations-$83,362K (-787.41%↓ Y/Y)Total other income(expense)-$6,689K (-10.67%↓ Y/Y)Unrealized gain onavailable-for-sale securities, net-$183K (-771.43%↓ Y/Y)Revenues$6,393K (-92.82%↓ Y/Y)Investment income$2,003K (-19.91%↓ Y/Y)Interest income fromlicensing$16K (-36.00%↓ Y/Y)Total operatingexpenses$89,755K (16.74%↑ Y/Y)Interest expense$8,708K (1.61%↑ Y/Y)Research and development$57,339K (8.01%↑ Y/Y)General andadministrative$21,306K (4.71%↑ Y/Y)Cost of license androyalty revenues$11,074K (222.29%↑ Y/Y)Other operatingexpenses-$36K (-140.00%↓ Y/Y)

REGENXBIO Inc. (RGNX)

REGENXBIO Inc. (RGNX)